- **Q: What are the terms of Mika Zibanejad's contract?
**
Sports / NHL
Speculation is mounting that the New York Rangers and Mika Zibanejad may be heading for a split. With Zibanejad possessing a full no-move clause, the decision ultimately rests with him, but recent reports suggest he might be more open to a...
Mika Zibanejad, the Rangers' longest-tenured player after the Chris Kreider trade, holds considerable value despite a slightly down year. His versatility, demonstrated by his ability to play both center and wing, makes him an attractive asset for various teams.
Trading Zibanejad would necessitate the Rangers finding a way to replace his approximately 60 goals per season. The Maple Leafs, looking to bolster their middle-six center depth, could be a viable landing spot. A proposed trade involves Zibanejad heading to Toronto in exchange for Max Domi, a move that would free up cap space for the Rangers while providing the Leafs with a potent offensive weapon.
However, Zibanejad's contract, which has five years remaining at an $8.5 million AAV, and his no-move clause complicate any potential deal. The Rangers' recent trades of Jacob Trouba and Kaapo Kakko signal a shift in team direction, potentially paving the way for Zibanejad's exit.
**
**
Do you think the Rangers should trade Zibanejad? Let us know in the comments! Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.